Asthma. Mild persistent asthma
Conditions
Interventions
Intervention 1: Intervention group 1: Lactobacillus rhamnosus probiotic group. The amount of 10 drops of this probiotic will be given daily and orally with the dropper. Intervention 2: Intervention gr
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
10 Years to 18 Years
Inclusion criteria
Inclusion criteria: Patients between 10 - 18 years A well-known case of persistent moderate asthma that has just been diagnosed and, has a medical record and approval from an asthma and allergy specialist. All patients are taking fluticasone spray. Have no history of other respiratory illnesses including interstitial pneumonia, cystic fibrosis, sickle cell disease, and primary ciliary dyskinesia
Exclusion criteria
Exclusion criteria: Immigration or death of the patient. Patient dissatisfaction in continuing the treatment. In case of other infectious or chronic diseases during the research period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of asthma control, interleukin 13, blood eosinophil percentage, forced expiratory volume, peak expiratory flow, forced vital capacity. Timepoint: At the beginning of the study and two months after the intervention. Method of measurement: Asthma control test(ACT), spirometry, CBC diff, IL13 human kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarnaz Sadat Javanmardi
Yasouj University of Medical Sciences
Outcome results
None listed